Navigation Links
Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
Date:9/9/2010

ersen, a.k.a. RB007).  Anivamersen can be used to selectively completely or partially reverse the anticoagulant effect of pegnivacogin.  REG1, presently in a phase 2b clinical trial (the RADAR trial), is intended for application in arterial thrombosis applications, initially in Acute Coronary Syndrome patients intended for Percutaneous Coronary Intervention.  A clinical program in Open Heart Surgery [including coronary artery bypass grafting (CABG) and valve repair/replacement] is also under development.  REG2, Regado's second product candidate, consists of a subcutaneously administered depot formulation of pegnivacogin paired with the IV bolus formulation of anivamersen.  REG2 recently completed single escalating dose phase 1 clinical testing (the first successful subcutaneous application of an aptamer in humans) and is planned to be studied in a multiple escalating dose clinical trial in late 2010 or early 2011.  It is intended for use in venous thrombosis indications such as venous thromboembolism (VTE) prophylaxis in patients undergoing abdominal surgery.  REG3, Regado's third program, consists of a specific GPVI inhibitor and its active control agent (RB571 and RB515, respectively).  REG3 is planned to enter phase 1 human clinical testing in 2011 and will be indicated for antiplatelet therapy.  Information pertaining to Regado's clinical programs may be obtained at www.clinicaltrials.gov.

ABOUT APTAMERS

Pegnivacogin is a member of a class of compounds called aptamers.  Aptamers are single stranded oligonucleotides that adopt a specific conformation enabling direct, specific inhibition of the targeted protein.  A key unique feature of aptamers derives from the fact that they are formed from nucleic acids.  As such, their pharmacologic activity can be controlled by a matched, complementary oligonucleotide active control agent (the W
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
2. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
3. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
4. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
5. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
6. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
7. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
8. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
9. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
10. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
11. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015 RnRMarketResearch.com adds Corneal ... report to its store. This report p provides ... The report "Corneal Ulcers - Pipeline Review, H2 ... for Corneal Ulcers. Corneal Ulcers are primarily result ... viral infections & fungal infections. The symptoms of ...
(Date:2/26/2015)... , Feb. 26, 2015  Today the ... The psychological and physical side effects of pain ... opioid painkillers, such as Vicodin and Oxycontin, are safer ... Americans overdose on prescription painkillers than on heroin and ... and CEO of NSC. "Yet, these medications are marketed ...
(Date:2/26/2015)... WASHINGTON , Feb. 26, 2015  Mail-service ... consumers, employers and government health plans ... research released by the Pharmaceutical Care Management Association ... specialty drugs offers one of the easiest ways ... CEO Mark Merritt . "Policymakers should resist ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
... Cumberland Pharmaceuticals Inc.(Nasdaq: CPIX ) today announced the ... of the supplemental new drug application (sNDA) for the use ... acute liver failure. The review has been extended by three ... (PDUFA) goal date in December 2010. "We ...
... 20 The European Patent Office ("EPO") Board ... to uphold European Patent No. EP 1307131 for ... http://photos.prnewswire.com/prnh/20061011/SFW044LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20061011/SFW044LOGO ... 26th, keeps the GlideScope patent in force in ...
Cached Medicine Technology:Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 3European Patent Office Upholds GlideScope® Video Laryngoscope Patent 2
(Date:3/1/2015)... 01, 2015 Researchers say working around ... many sheet metal workers contract malignant mesothelioma. Surviving Mesothelioma ... on its website. Click here to read it ... Research and Training monitored 17,345 sheet metal workers from ... of them died of mesothelioma or another asbestos-related ...
(Date:3/1/2015)... Indianapolis, Indiana (PRWEB) March 01, 2015 ... Indiana statewide Network Service Provider, announces NewWays Networking, ... provider. “By working with IFN, NewWays is ... to meet client’s demand for Internet bandwidth in ... Owner/Manager. , According to Cory Childs IFN ...
(Date:3/1/2015)... CrossFit Attollo is a CrossFit gym located in Vancouver ... to new members. Now through the end of March ... will receive their fourth month half off. , ... The three month contract is only $264, dropping the price ... comes in at only $55. The special saves new members ...
(Date:2/28/2015)... In a recent episode of SCI TV ... Athlete Development Services and Consultancy talks with Joshua ... development and player engagement during and after their careers. ... face and how off-field activities are a critical component ... in athlete development issues while in graduate school coaching ...
(Date:2/28/2015)... 2015 The Classic Denture Center ... new special. Throughout all of March patients can ... This service can help overall mouth health ... Patients may notice certain symptoms that suggest the denture ... symptoms include: , 1.    Pain, clicking, and popping in the ...
Breaking Medicine News(10 mins):Health News:New Study Finds Indirect Asbestos Exposure Can Raise Mesothelioma Risk for Sheet Metal Workers, According to Surviving Mesothelioma 2Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2
... Corresponding Journal of Nutrition supplement urges health professionals to ... to be published in the June issue of the ... and the general public to stop demonizing high fructose ... rethink the myths about high fructose corn syrup,s impact ...
... NAS to Store Public Database of Genomic and Trait Data ... Isilon(R) Systems (Nasdaq: ISLN ), the ... Personal Genome Project (PGP) has deployed Isilon ... for an unprecedented research project aimed at transforming the use ...
... Keeping Up on Developments in the Long term Care Insurance ... interest in long term care insurance need no longer dig ... pros do: have the information come to them, in bits ... secrets," says Jonas Roeser, Senior Vice President of Marketing & ...
... on lung cancer and mesothelioma specialists into one of ... asbestos-related diseases. Our searchable, easy-to-use database contains doctor profiles ... it easy for residents of California or New York, ... in their area. , ...
... medical malpractice challenge by introducing low tech solution ... introduces standardized shift reporting and note taking to ... to day tasks.RNReport Card is more efficient by ... It fits conveniently in the pocket of your ...
... Packard Children,s Hospital and the Stanford University School of ... deadly and mysterious bowel disease that strikes medically fragile ... understanding of the disease and its medical management, and ... major killer of children and young adults. , The ...
Cached Medicine News:Health News:Experts Lay to Rest Long-Held Misconceptions About High Fructose Corn Syrup at ILSI-USDA Workshop 2Health News:Experts Lay to Rest Long-Held Misconceptions About High Fructose Corn Syrup at ILSI-USDA Workshop 3Health News:The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research 2Health News:The Personal Genome Project Deploys Isilon IQ Storage to Transform Genomic Research 3Health News:Long Term Care Alerting Methods Revealed by Industry Leaders 2Health News:MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists 2Health News:MesotheliomaHelp.net Announces Expanded Information on Lung Cancer and Mesothelioma Specialists 3Health News:RN Sisters Bring Low-Tech Innovations to New Nurses and Nursing Students 2Health News:Packard/Stanford study suggests two causes for bowel disease in infants 2Health News:Packard/Stanford study suggests two causes for bowel disease in infants 3
14mm from Mid-Screw to Tip, Slightly Curved, Sharp Tips; overall length 110mm; Stainless Steel....
9mm Curved Blades with Sharp Pointed Tips; overall length 90mm; Stainless Steel....
4 Gently Curved, Prongs, 5mm Extended, Stainless Steel Tip; with Titanium Handle....
12mm from bend to 0.12mm 1x2 teeth; In Titanium....
Medicine Products: